Multiomic DNA Test for Heart Disease May Save Health Insurers Millions
Cardio Diagnostics’s multiomic DNA test showed an ability to save up to $113.6 million annually for a health plan with one million members.
Read MorePosted by Andy Lundin | Apr 29, 2024 | Molecular Diagnostics |
Cardio Diagnostics’s multiomic DNA test showed an ability to save up to $113.6 million annually for a health plan with one million members.
Read MorePosted by Andy Lundin | Apr 24, 2024 | Molecular Diagnostics |
The partnership aims to provide patients with greater accessibility and convenience in accessing whole genome sequencing tests.
Read MorePosted by Andy Lundin | Apr 23, 2024 | Heart Disease |
Researchers in the U.S. and the Netherlands have now used a large dataset to build more accurate cardiovascular risk models.
Read MorePosted by Andy Lundin | Apr 22, 2024 | Dementias & Alzheimer’s |
Quest Diagnostics expanded its AD-Detect portfolio of Alzheimer’s tests by adding a blood biomarker test for early disease diagnosis.
Read MorePosted by Andy Lundin | Apr 18, 2024 | Cancer |
Unilabs will use the SOPHiA DDM Platform to test for Homologous Recombination Deficiency in solid tumors, particularly in ovarian cancer.
Read More